ARCHIVES

Critics of FDA misunderstand Bayesian analysis, statisticians say.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

ACS Clinical Awards Available For 1996

March 31, 1995

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

February 14, 1986